<p>Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials</p>Na Wang, Xianfeng Zhang, Tao Yang et al.|Diabetes Metabolic Syndrome and Obesity|2019Cited by 11